Your SlideShare is downloading. ×
0
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Coughlin_IFT Webinar_Caffeine Safety_November 2013
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Coughlin_IFT Webinar_Caffeine Safety_November 2013

99

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
99
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Caffeine Safety: A Three-Decade Review…and the 2013 Landscape James R. Coughlin, PhD CFS President, Coughlin & Associates Aliso Viejo, California jrcoughlin@cox.net www.linkedin.com/in/jamescoughlin Institute of Food Technologists Webinar: “The Buzz on Caffeine: New Developments in Safety, Regulation and Adverse Event Reporting“ “November 12, 2013
  • 2. Outline • My Historical Perspective on Caffeine & Health Issues • Caffeine in 2013… • Energy Drinks, other Foods/Beverages • Congressional, FDA, Health Canada, EFSA, FSANZ Activities • Where do we go from here? 2
  • 3. A 30+ Year Perspective on Caffeine/Health …on Rats, Mice & Humans …on Almost Every Disease …on “Good” & “Bad” Science and Policy …on “Good” & “Bad” Media Coverage …on Caffeine’s Beneficial Health Effects 3
  • 4. Much Confusion over Caffeine “Perhaps no substance has been the subject of more conflicting media and scientific reports in recent years than caffeine. So, is a cup of coffee bad for you or not?” Los Angeles Times, September 11-13, 1994 risk series - But no one was even asking back then - “So, is a cup of coffee (or caffeine) good for you or not?” 4
  • 5. Caffeine/Health Conclusions: 1978 - 2013 … First 20 Years: Mostly Bad News! Caffeine was linked to many animal toxicities and human disease! … Last 15 or so years…Very Big Turn Around: The “Good News” is that almost all of the Bad News about caffeine was WRONG! 5
  • 6. Caffeine’s “Maligning” Started in the Late 1970’s and Ballooned in the 1980’s and Early 1990’s • Coffee and heart attacks, was it the caffeine? • Caffeine and birth defects in rats (U.S. FDA, 1978); reproductive & developmental effects in humans • Caffeine and urinary calcium loss, osteoporosis • Caffeine anxiety, sleep disturbance, “addiction” 6
  • 7. Caffeine and Reproductive Effects • Began with birth defects (missing digits) in rats gavaged (force-fed) very high-doses (FDA, 1978) • Then human studies followed: delayed conception; premature birth; low birth weight babies; fetal death; spontaneous abortion (miscarriage), congenital defects • But now there are more than 25 published reviews supporting caffeine’s safety: • Peck, Leviton, Cowan (Food Chem. Toxicol. 2010) • Brent, Christian, Diener (Birth Defects Res. 2011) 8
  • 8. Caffeine and Osteoporosis • Excess calcium loss & bone loss in post-menopausal women causes millions of bone fractures (mostly hip) • Earlier acute, 24-hour human studies on non-caffeine consuming subjects were originally misinterpreted • Many longer-term, human clinical studies have shown little excess calcium loss or bone loss and no increased risk of osteoporosis. 9
  • 9. Caffeine and “Addiction” 10
  • 10. Caffeine and “Addiction” • Dependence, tolerance and withdrawal headache were cited in many published studies (mostly among psychiatric patients) • Headlines since the late 1980’s: • “Caffeine Addiction More Than Just Java Jive -- Caffeine Junkies” • “Study Finds Caffeine Has Qualities of Addictive Drug” • Current view is very reassuring: • Caffeine is not classified as an addictive drug (APA, DSM-5 psychiatric “bible” published May 2013) • Addiction over-warnings trivialize dangers of real drugs of abuse. 11
  • 11. What Science Allowed the Bad Myths to Happen… and Why have Some New Myths Popped Up? … Acute vs. Chronic effects:  Partial / full tolerance to caffeine develops in humans consistently consuming caffeine and coffee daily … Most of the Myths and Fears are based on:  Acute effects’ testing of non-coffee consuming subjects  Massive doses of caffeine fed to animals for a lifetime  Smaller, poorly conducted human studies …Failure to Know the Vast Literature 12
  • 12. Caffeine’s Beneficial Physiological Effects • Mild central nervous system (CNS) stimulant • Improves cognitive performance and mental processing; increases wakefulness; improves work performance and enhances mood • Increases capacity for physical work & exercise; improves muscular performance and endurance sports • Relaxes smooth muscle, especially bronchial (opens airways), and increases blood flow in heart and kidneys • Produces a slightly higher metabolic rate (some evidence of an ergogenic “fat burning” effect). 13
  • 13. “Risk Reductions” with Caffeine Consumption • Parkinson’s Disease • Alzheimer’s Disease • Depression & suicide 14
  • 14. So with all this more recent good news, why are we still worrying about Caffeine? ~ New safety concerns have been raised for Energy Drinks and New Products containing Caffeine. 15
  • 15. Recent Studies/Reviews on Energy Drinks? ~ …by researchers who do not know the 30-years of caffeine literature 16
  • 16. 17
  • 17. 18
  • 18. 19
  • 19. 20
  • 20. 21
  • 21. 22
  • 22. U.S. FDA Concerns over Caffeine and Energy Drinks 23
  • 23. “Experts” Letter to FDA Commissioner 24
  • 24. Added Caffeine in Gum - FDA Statement on Wrigley’s Announcement (May 8, 2013) Michael R. Taylor, FDA Deputy Commissioner for Foods and Veterinary Medicine, provided this response to Wrigley's announcement regarding withdrawal of Alert Energy Caffeine Gum: On May 8, 2013, Wrigley (a subsidiary of Mars) announced its decision to pause production, sales, and marketing of Alert Energy Caffeine Gum. This announcement was made following a series of discussions with the FDA in which the agency expressed concerns about caffeine appearing in a range of new foods and beverages. The FDA applauds Wrigley’s decision and its recognition that we need to improve understanding and, as needed, strengthen the regulatory framework governing the appropriate levels and uses of caffeine in foods and beverages. The company’s action demonstrates real leadership and commitment to the public health. We hope others in the food industry will exercise similar restraint. We look forward to working with industry, the scientific and medical community, and all interested parties to address the issues posed by added caffeine in foods and beverages. 25
  • 25. Backgrounder for the Institute Of Medicine (IOM) FDA-Requested Workshop on Potential Health Hazards of Caffeine In Food and Dietary Supplements (6/28/2013) – 21 Questions Posed • Exposure • Absorption, distribution, metabolism, and excretion (ADME) • Cardiovascular effects • Neurological and behavioral effects • Tolerance and withdrawal • Population risk characteristics • Scientific data on caffeine 26
  • 26. 27
  • 27. 28
  • 28. 29
  • 29. 30
  • 30. • Goal - To bring together and summarize relevant research on the use and biology of Energy Drinks and to highlight the most critical research gaps. • Sponsored by NIH Office of Dietary Supplements and several other NIH Institutes. • Talks focused on patterns of use, sensitive subpopulations, safety and health effects of Energy Drinks and their ingredients. 31
  • 31. Taylor’s Blog on Caffeine 32
  • 32. Other Regulatory Agencies Concerns 33
  • 33. 34
  • 34. European Food Safety Authority • EFSA. Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food, on a request from the Commission on the use of taurine and D-glucurono-γ-lactone as constituents of the so-called “energy” drinks. EFSA Journal (2009) 935, 1-31. • Zucconi et al., 2013. “Gathering consumption data on specific consumer groups of energy drinks.” [190 pp.] www.efsa.europa.eu/publications • EFSA opinion on caffeine’s safety requested by the European Commission (Feb 2013): • Delays any authorization of certain health claims from art. 13.1 • Maximum levels of caffeine intake from all sources • Risk of interaction of caffeine with alcohol and other ingredients of “Energy drinks” • Population groups: population in general, adults performing physical activities of various intensities, pregnant women, lactating women, children and adolescents • EFSA may issue its opinion within six months. 35
  • 35. Food Standards Australia New Zealand (FSANZ) 36
  • 36. 37
  • 37. ILSI – “Beverage Caffeine Intakes in the U.S.” • 96% of beverage caffeine consumed is from coffee, soft drinks and tea • Coffee remains the largest contributor to beverage caffeine intakes • Energy drinks, energy shots and chocolate beverages contribute little to caffeine intakes • Only 4.3% of all caffeinated beverage consumers were consumers of energy drinks • In teenagers (13–17 years) or young adults (18–24 years), 9-10% of caffeinated beverage consumers were consuming energy drinks • Intakes from energy drinks represent less than 2% of total daily mean caffeine values for all caffeinated beverage consumers. 38
  • 38. What Happens Next? ~ Thank You!

×